Delayed Stroke Treatment during COVID-19 Pandemic in China
Conclusions: COVID-19 pandemic has remarkable impacts on the management of AIS. Both pre- and posthospital delays were prolonged significantly, and proportion of patients arrived within the 4.5-h time window for intravenous thrombolysis treatment was decreased. Given that anti-COVID-19 measures are becoming medical routines, efforts are warranted to shorten the delay so that the outcomes of stroke could be improved.Cerebrovasc Dis
Source: Cerebrovascular Diseases - Category: Neurology Source Type: research
More News: China Health | COVID-19 | Education | Ischemic Stroke | Neurology | Outbreaks | Pandemics | Residencies | Rural Health | Stroke | Study